ADVERTISEMENT

Mphasis Share Price Gains As Q2 Profit Meets Estimates

The net profit of Mphasis rose 4.6% on a sequential basis to Rs 423 crore, in line with Bloomberg's estimate of Rs 416 crore.

<div class="paragraphs"><p>Mphasis share price has risen 31% in the last 12 months and 10% on a year-to-date basis.</p></div>
Mphasis share price has risen 31% in the last 12 months and 10% on a year-to-date basis.

Mphasis Ltd.'s share price gained on Thursday after the company announced the July-September quarter earnings with the profit meeting analysts' estimates. The net profit of the company rose 4.6% on a sequential basis to Rs 423 crore, according to an exchange filing. Analysts' consensus estimates compiled by Bloomberg had projected a net profit of Rs 416 crore.

Revenue increased 3.3% to Rs 3,536 crore from Rs 3,422 crore in the second quarter of fiscal 2024. The Bloomberg estimate was Rs 3,516 crore.

Operating profit, or EBIT, advanced 6% to Rs 544 crore, compared to Rs 514 crore in the previous quarter. EBIT margin improved from 15% to 15.4%, within the target band of 14.6% to 16%.

The total contract value for the quarter was $207 million, which includes three large deals secured during the period, the company said in an investor presentation.

Mphasis said the TCV wins are broad-based across verticals, client pyramids, and strategic customers, and the pace of conversion to revenue has picked up.

Opinion
Mphasis Appoints Ajay Arya As Head Of Mergers, Acquisitions

Mphasis Share Price Movement

<div class="paragraphs"><p>Mphasis stock was trading 3% higher at Rs 2,999 by 10:25 a.m.</p></div>

Mphasis stock was trading 3% higher at Rs 2,999 by 10:25 a.m.

Shares of Mphasis advanced 4.4% intraday to Rs 3,039 apiece. The scrip was trading 3% higher at Rs 2,999 as of 10:25 a.m. The benchmark NSE Nifty 50 was down 0.6%.

The stock has risen 31% in the last 12 months and 10% on a year-to-date basis. The total traded volume so far in the day stood at 8.4 times its 30-day average. The relative strength index was at 40.

Fifteen out of the 35 analysts tracking Mphasis have a 'buy' rating on the stock, 10 recommend a 'hold' and 10 suggest a 'sell', according to Bloomberg data. The average of 12-month analyst price target of Rs 2,989 implies a potential upside of 0.5%.

Opinion
Infosys Q2 Results Preview: Revenue, Profit Likely To Improve, Guidance May Be Raised